Clinical Research

Thumbnail

Thinner gray matter ribbons signal dementia risk

Researchers examined decade-old MR images from Framingham Heart Study participants to develop their observation.

Thumbnail

AI spots missed findings on chest X-rays, aiding nonradiologists in emergency setting

Emergency units often lack 24/7 coverage by radiologists, presenting an opportunity for AI to aid in diagnostics.

Hip strain injury fracture broken hip

AI model predicts hip fractures in a short-term timeframe

Current risk assessments are unable to calculate the likelihood of a near-future fracture after a patient breaks their hip.

Thumbnail

Study examines use of MSOT for detecting pancreatic cancer, improving surgery

The University of Oklahoma Health has earned a $3 million grant from the National Cancer Institute for this project.

heart surgery surgeons

SAVR in the TAVR era: Volumes are down, but it remains the go-to choice for certain patient populations

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves. 

Esolution device S4 Medical PFA ablation esophagus

New medical device helps cardiologists limit esophageal injuries during RF ablation procedures

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries. 

ACC 2023 ACC.23 American College of Cardiology

American College of Cardiology announces late-breaking research for ACC.24 in Atlanta

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

Thumbnail

Mutations in three-dimensional structures of the genome may be a cause of autism

The study involved an analysis of the genomic data from 5,000 families and could lead to new treatments.